Home › Calculator › RNAZ Dividend Calculator 2026
RNAZ Dividend Calculator 2026
No dividendHealthcareTransCode Therapeutics, Inc. · NASDAQ
Price: $1.73 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
RNAZ is not a dividend-focused stock
RNAZ pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
RNAZ Dividend Yield
TransCode Therapeutics, Inc. (RNAZ) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RNAZ pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About TransCode Therapeutics, Inc. (RNAZ) — Dividend Analysis 2026
TransCode Therapeutics, Inc. is a biopharmaceutical firm dedicated to pioneering and marketing therapeutic agents and diagnostic tools specifically aimed at combating and detecting metastatic disease. Central to its pipeline is TTX-MC138, a lead therapeutic compound currently undergoing preclinical evaluation for its potential in treating advanced, spreading cancers. Beyond its primary candidate, the company's preclinical portfolio also features TTX-siPDL1, an siRNA designed to modulate programmed death-ligand 1, and TTX-siLIN28B, another siRNA that inhibits the RNA-binding protein LIN28B. TransCode also pursues several cancer-agnostic initiatives. These encompass TTX-RIGA, an RNA-based agent engineered to stimulate the RIG-I immune pathway within the tumor's immediate surroundings; TTX-CRISPR, a gene-editing platform utilizing CRISPR/Cas9 technology to correct or eradicate oncogenic genes within cancer cells; and TTX-mRNA, an innovative mRNA platform dedicated to creating cancer vaccines that incite powerful cytotoxic immune reactions against malignant cells. Established in 2016, TransCode Therapeutics is headquartered in Boston, Massachusetts.
RNAZ Dividend & DRIP — Frequently Asked Questions
Does RNAZ pay a dividend?
No. TransCode Therapeutics, Inc. (RNAZ) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of RNAZ?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does RNAZ have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. RNAZ has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to RNAZ
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RNAZ DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RNAZ position with:
🌍 RNAZ Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RNAZ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RNAZ Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RNAZ Dividend Payment Schedule
RNAZ pays quarterly — 4 times per year. Ex-div: —.
📊 RNAZ vs Healthcare Benchmarks
How RNAZ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RNAZ sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RNAZ Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-09-09 | 185,000 | $1.78 | $329.3K | ||
| C-Conversion | 2026-08-03 | 2,020,582 | $0.00 | $202.00 | ||
| C-Conversion | 2026-08-03 | 11,813,859 | $0.00 | $1.2K | ||
| C-Conversion | 2026-08-03 | 1,181.386 | — | — | ||
| C-Conversion | 2026-08-03 | 202.058 | — | — | ||
| Other | 2026-07-27 | 2,020,582 | — | — | ||
| Other | 2026-07-27 | 11,813,859 | — | — | ||
| A-Award | 2024-06-14 | 70,000 | $1.20 | $84.0K | ||
| A-Award | 2024-06-14 | 70,000 | $1.20 | $84.0K | ||
| A-Award | 2024-06-14 | 650,000 | $1.20 | $780.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare RNAZ with peers: RNAZ vs ACXP · RNAZ vs APRE · RNAZ vs APVO
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RNAZ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
TransCode Therapeutics, Inc. (RNAZ) is currently trading at $1.73, 88% below its 52-week high. It does not currently pay a regular dividend.
Does RNAZ Pay a Dividend? TransCode Therapeutics, Inc. Dividend Status
TransCode Therapeutics, Inc. (RNAZ) is a healthcare stock trading at $1.73. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest RNAZ News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your RNAZ DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.